| Bos taurus |
Thrombin |
IC50 |
10000.0 |
nM |
10.1016/j.bmc.2014.12.056 |
| Cavia porcellus |
Cavia porcellus |
Inhibition |
31.7 |
% |
10.1016/s0960-894x(02)00393-1 |
| Cavia porcellus |
Cavia porcellus |
Inhibition |
51.8 |
% |
10.1016/s0960-894x(02)00393-1 |
| Cricetinae gen. sp. |
Cricetinae gen. sp. |
ID50 |
0.082 |
mg.kg-1 |
10.1021/jm990412m |
| Homo sapiens |
A549 |
IC50 |
nan |
None |
10.1016/j.bmcl.2011.01.083 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
142200.0 |
nM |
10.1124/dmd.112.047068 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cathepsin G |
IC50 |
10000.0 |
nM |
10.1016/j.bmc.2014.12.056 |
| Homo sapiens |
Cathepsin G |
IC50 |
100000.0 |
nM |
10.1021/jm4011725 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HEK-293T |
IC50 |
100000.0 |
nM |
10.1021/jm4011725 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-2.63 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
30.36 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Kallikrein 1 |
IC50 |
2000.0 |
nM |
10.1021/jm4011725 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Leukocyte elastase |
IC50 |
3.5 |
nM |
10.1016/j.bmc.2020.115756 |
| Homo sapiens |
Leukocyte elastase |
IC50 |
10.0 |
nM |
10.1021/jm4011725 |
| Homo sapiens |
Leukocyte elastase |
IC50 |
44.0 |
nM |
10.1016/j.bmc.2011.06.036 |
| Homo sapiens |
Leukocyte elastase |
IC50 |
44.0 |
nM |
10.1016/s0960-894x(02)00393-1 |
| Homo sapiens |
Leukocyte elastase |
IC50 |
44.0 |
nM |
10.1021/acs.jmedchem.0c00776 |
| Homo sapiens |
Leukocyte elastase |
IC50 |
44.0 |
nM |
10.1021/jm990412m |
| Homo sapiens |
Leukocyte elastase |
IC50 |
50.0 |
nM |
10.1016/j.bmc.2020.115836 |
| Homo sapiens |
Leukocyte elastase |
IC50 |
50.0 |
nM |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
70.0 |
nM |
10.1016/j.bmc.2014.12.056 |
| Homo sapiens |
Leukocyte elastase |
IC50 |
128.0 |
nM |
10.1016/j.bmc.2020.115756 |
| Homo sapiens |
Leukocyte elastase |
IC50 |
136.0 |
nM |
10.1021/jm3017305 |
| Homo sapiens |
Leukocyte elastase |
IC50 |
704.0 |
nM |
10.1021/acs.jmedchem.1c01583 |
| Homo sapiens |
Leukocyte elastase |
IC50 |
65040.0 |
nM |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
338220.0 |
nM |
None |
| Homo sapiens |
Leukocyte elastase |
Inhibition |
nan |
% |
10.1021/acsmedchemlett.7b00533 |
| Homo sapiens |
Leukocyte elastase |
Inhibition |
nan |
% |
10.1021/jm3017305 |
| Homo sapiens |
Leukocyte elastase |
K |
0.00113 |
/s |
10.1021/acsmedchemlett.7b00533 |
| Homo sapiens |
Leukocyte elastase |
K |
30300.0 |
/M/s |
10.1021/acsmedchemlett.7b00533 |
| Homo sapiens |
Leukocyte elastase |
Ki |
24.0 |
nM |
10.1016/j.bmcl.2021.128380 |
| Homo sapiens |
Leukocyte elastase |
Ki |
37.0 |
nM |
10.1021/acsmedchemlett.7b00533 |
| Homo sapiens |
Leukocyte elastase |
Ki |
200.0 |
nM |
10.1021/acs.jmedchem.0c00776 |
| Homo sapiens |
Leukocyte elastase |
Ki |
200.0 |
nM |
10.1021/jm990412m |
| Homo sapiens |
Leukocyte proteinase 3 |
IC50 |
340.0 |
nM |
10.1016/j.bmc.2014.12.056 |
| Homo sapiens |
Leukocyte proteinase 3 |
IC50 |
100000.0 |
nM |
10.1021/jm4011725 |
| Homo sapiens |
LoVo |
Inhibition |
15.0 |
% |
10.1016/j.bmcl.2011.01.083 |
| Homo sapiens |
LoVo |
Inhibition |
20.0 |
% |
10.1016/j.bmcl.2011.01.083 |
| Homo sapiens |
MCF7 |
Inhibition |
61.0 |
% |
10.1016/j.bmcl.2011.01.083 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Plasma |
Stability |
nan |
% |
10.1021/jm4011725 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thrombin |
IC50 |
2000.0 |
nM |
10.1021/jm4011725 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Trypsin |
IC50 |
2000.0 |
nM |
10.1021/jm4011725 |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Urokinase-type plasminogen activator |
IC50 |
2000.0 |
nM |
10.1021/jm4011725 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/acs.jmedchem.1c01583 |
| Mus musculus |
Mus musculus |
FC |
1.0 |
None |
10.1021/acs.jmedchem.1c01583 |
| Mus musculus |
Mus musculus |
Inhibition |
nan |
% |
10.1016/j.bmc.2014.12.056 |
| Mus musculus |
Neutrophil elastase |
IC50 |
145.39 |
nM |
10.1016/j.bmc.2014.12.056 |
| Mus musculus |
NIH3T3 |
IC50 |
100000.0 |
nM |
10.1021/jm4011725 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Liver microsome |
T1/2 |
0.3317 |
hr |
10.1021/jm4011725 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
11.1 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.1753 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.02 |
% |
10.6019/CHEMBL4495565 |
| Sus scrofa |
Pancreatic elastase |
IC50 |
2185.17 |
nM |
10.1016/j.bmc.2014.12.056 |
| Sus scrofa |
Pancreatic elastase |
IC50 |
50000.0 |
nM |
10.1021/jm4011725 |
| None |
Neutrophil |
IC50 |
50.0 |
nM |
10.1016/j.bmc.2014.12.056 |
| None |
Neutrophil |
IC50 |
20000.0 |
nM |
10.1016/j.bmc.2014.12.056 |
| None |
Neutrophil |
IC50 |
50000.0 |
nM |
10.1021/np500057b |
| None |
NON-PROTEIN TARGET |
Potency |
33.5 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
1495.0 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
4213.5 |
nM |
None |
| None |
No relevant target |
Stability |
nan |
% |
10.1021/jm4011725 |
| None |
Unchecked |
Activity |
55.1 |
% |
10.1021/jm3017305 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acs.jmedchem.0c01683 |
| None |
Unchecked |
IC50 |
44.0 |
nM |
10.1021/acs.jmedchem.1c01583 |
| None |
Unchecked |
IC50 |
1947.06 |
nM |
10.1016/j.bmc.2014.12.056 |
| None |
Unchecked |
IC50 |
2000.0 |
nM |
10.1021/jm4011725 |
| None |
Unchecked |
IC50 |
2810.0 |
nM |
10.1021/jm3017305 |
| None |
Unchecked |
IC50 |
2960.0 |
nM |
10.1021/acs.jmedchem.1c01583 |
| None |
Unchecked |
IC50 |
4084.0 |
nM |
10.1021/jm3017305 |
| None |
Unchecked |
IC50 |
10000.0 |
nM |
10.1016/j.bmc.2014.12.056 |
| None |
Unchecked |
IC50 |
10000.0 |
nM |
10.1021/jm3017305 |
| None |
Unchecked |
Ratio IC50 |
5.2 |
None |
10.1016/j.bmc.2014.12.056 |
| None |
Unchecked |
Ratio IC50 |
29.94 |
None |
10.1016/j.bmc.2014.12.056 |
| None |
Unchecked |
Ratio IC50 |
153.75 |
None |
10.1016/j.bmc.2014.12.056 |